Post-Conference Perspectives Year in Review: 2023 Developments in Advanced or Recurrent Endometrial Cancer - Episode 2
Drs Backes and Powell highlight key advances in endometrial cancer treatment from the 2023 SGO, ASCO, and ESMO conferences, including HER2-targeted therapies showing promising response rates.